FOLD - Company ID 0001178879
The table below shows AMICUS THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $190.55M | $158.70M | $181.66M | $233.65M | $209.34M | $209.76M |
| Short-term investments | $73.29M | $72.30M | $68.92M | $16.11M | $50.73M | $29.84M |
| Receivables | $113.84M | $105.85M | $88.32M | $98.07M | $85.17M | $76.43M |
| Inventory | $177.93M | $154.88M | $132.41M | $115.34M | $81.32M | $60.76M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $594.07M |
| $538.01M |
| $510.80M |
| $498.47M |
| $461.70M |
| $431.24M |
| Property, plant & equipment | $27.76M | $28.57M | $28.72M | $30.44M | $31.16M | $32.42M |
| Goodwill | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M | $197.80M |
| Total assets | $868.81M | $815.30M | $789.84M | $786.56M | $749.48M | $721.79M |
| Accounts payable | $19.10M | $13.89M | $14.45M | $13.48M | $32.06M | $9.21M |
| Total current liabilities | $198.93M | $167.65M | $152.89M | $158.14M | $168.07M | $142.10M |
| Long-term debt | $391.99M | $391.32M | $390.71M | $389.49M | $388.94M | $388.39M |
| Total liabilities | $638.39M | $611.00M | $596.28M | $607.73M | $616.96M | $591.10M |
| Retained earnings | -$2.77B | -$2.79B | -$2.76B | -$2.75B | -$2.75B | -$2.73B |
| Total equity | $230.42M | $204.30M | $193.56M | $178.82M | $132.52M | $130.69M |